Search Results - "Kuntz, Nancy L."
-
1
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
Published in Neuromuscular disorders : NMD (01-11-2019)“…•NURTURE is an ongoing study of nusinersen started in a presymptomatic stage of SMA.•All infants were ≥25 months old, and alive without permanent…”
Get full text
Journal Article -
2
Combination molecular therapies for type 1 spinal muscular atrophy
Published in Muscle & nerve (01-10-2020)“…Background Data on combining molecular therapies that increase survival motor neuron protein for spinal muscular atrophy type 1 (SMA1) is lacking. Methods This…”
Get full text
Journal Article -
3
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study
Published in PLoS medicine (01-09-2020)“…The differential mechanism of action of vamorolone compared to traditional corticosteroid anti-inflammatory drugs is attributed to the loss of gene…”
Get full text
Journal Article -
4
A multicenter, retrospective medical record review of X‐linked myotubular myopathy: The recensus study
Published in Muscle & nerve (01-04-2018)“…ABSTRACT Introduction: X‐linked myotubular myopathy (XLMTM), characterized by severe hypotonia, weakness, respiratory distress, and early mortality, is rare…”
Get full text
Journal Article -
5
Moderate exercise improves function and increases adiponectin in the mdx mouse model of muscular dystrophy
Published in Scientific reports (08-04-2019)“…The loss of dystrophin produces a mechanically fragile sarcolemma, causing muscle membrane disruption and muscle loss. The degree to which exercise alters…”
Get full text
Journal Article -
6
Medical management of muscle weakness in Duchenne muscular dystrophy
Published in PloS one (19-10-2020)“…Duchenne muscular dystrophy (DMD) is a childhood onset muscular dystrophy leading to shortened life expectancy. There are gaps in published DMD care guidelines…”
Get full text
Journal Article -
7
A case report of riboflavin transporter deficiency: A novel heterozygous pathogenic variant in the SLC52A3 gene
Published in Molecular genetics and metabolism reports (01-03-2024)“…Riboflavin transporter deficiency (RTD) is a neurodegenerative disorder that presents from infancy to adulthood with a progressive axonal neuropathy…”
Get full text
Journal Article -
8
Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming
Published in JCI insight (19-12-2019)“…In humans, chronic glucocorticoid use is associated with side effects like muscle wasting, obesity, and metabolic syndrome. Intermittent steroid dosing has…”
Get full text
Journal Article -
9
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
Published in Neurology (19-01-2021)“…OBJECTIVETo update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature…”
Get full text
Journal Article -
10
Postural Orthostatic Tachycardia Syndrome: A Clinical Review
Published in Pediatric neurology (01-02-2010)“…Postural orthostatic tachycardia syndrome was defined in adult patients as an increase >30 beats per minute in heart rate of a symptomatic patient when moving…”
Get full text
Journal Article -
11
Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial
Published in Muscle & nerve (01-09-2021)“…Introduction/Aims Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene resulting in the absence of dystrophin. Casimersen is a…”
Get full text
Journal Article -
12
Neuronal Voltage-Gated Potassium Channel Complex Autoimmunity in Children
Published in Pediatric neurology (01-04-2011)“…Autoimmunity targeting voltage-gated potassium channel complexes have not been systematically documented in children. Identified in the Neuroimmunology…”
Get full text
Journal Article -
13
Axonal Damage in Pediatric Multiple Sclerosis
Published in Pediatric neurology briefs (01-05-2015)“…Investigators from Georg August University, Gottingen, Germany, analyzed axonal pathology in brain biopsy and autopsy samples from 19 children with early…”
Get full text
Journal Article -
14
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
Published in Lancet neurology (01-04-2021)“…Spinal muscular atrophy type 1 is a motor neuron disorder resulting in death or the need for permanent ventilation by age 2 years. We aimed to evaluate the…”
Get full text
Journal Article -
15
Re: "Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy" by Wilson and Flotte
Published in Human gene therapy (01-08-2020)Get more information
Journal Article -
16
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
Published in The New England journal of medicine (02-11-2017)“…In this phase 3 trial, among infants with spinal muscular atrophy, those who received nusinersen were more likely to achieve major motor milestones and less…”
Get full text
Journal Article Web Resource -
17
Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report
Published in The Journal of pediatrics (01-11-2003)“…We report the successful use of anti-CD20 therapy in a child with refractory myasthenia gravis (MG), an antibody-mediated autoimmune disease, who did not…”
Get full text
Journal Article -
18
Hereditary Neuropathy with Liability to Pressure Palsies
Published in Pediatric neurology briefs (01-11-2015)“…Investigators from 4 pediatric hospitals in Canada analyzed the clinical presentation and electrophysiological data of 12 children with hereditary neuropathy…”
Get full text
Journal Article -
19
Laboratory Evaluation of Pediatric Autonomic Disorders
Published in Seminars in pediatric neurology (01-03-2013)“…The autonomic nervous system controls a variety of fundamental physiological processes in the human body including regulation of breathing, heart rate, blood…”
Get full text
Journal Article -
20
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Published in JAMA : the journal of the American Medical Association (19-04-2022)“…IMPORTANCE: Corticosteroids improve strength and function in boys with Duchenne muscular dystrophy. However, there is uncertainty regarding the optimum regimen…”
Get full text
Journal Article